haemo xl capsule (iron (iii) hydroxide polymaltose complex)
unimed sdn bhd - iron (iii) hydroxide polymaltose complex -
haemo xl syrup (iron (iii) hydroxide polymaltose complex)
unimed sdn bhd - iron (iii) hydroxide polymaltose complex -
venofer
cts ltd - ferrous as iron iii hydroxide sucrose complex - solution for injection - ferrous as iron iii hydroxide sucrose complex 20 mg/ml - iron-sorbitol-citric acid complex - iron-sorbitol-citric acid complex - venofer is indicated for the treatment of iron deficiency in the following indications:• where there is a clinical need for a rapid iron supply,• in patients who cannot tolerate oral iron therapy or who are non-compliant,• in active inflammatory bowel disease where oral iron preparations are ineffective,• in chronic kidney disease when oral iron preparations are less effective.the diagnosis of iron deficiency must be based on appropriate laboratory tests (e.g. hb, serum ferritin, tsat, serum iron, etc.)(hb haemoglobin, tsat transferrin saturation)
venofer
cts ltd - ferrous as iron iii hydroxide sucrose complex - solution for injection - ferrous as iron iii hydroxide sucrose complex 100 mg / 5 ml - iron-sorbitol-citric acid complex - iron-sorbitol-citric acid complex - venofer is indicated for the treatment of iron deficiency in the following indications:• where there is a clinical need for a rapid iron supply,• in patients who cannot tolerate oral iron therapy or who are non-compliant,• in active inflammatory bowel disease where oral iron preparations are ineffective,• in chronic kidney disease when oral iron preparations are less effective.the diagnosis of iron deficiency must be based on appropriate laboratory tests (e.g. hb, serum ferritin, tsat, serum iron, etc.)(hb haemoglobin, tsat transferrin saturation)
venofer iron 100mg/5ml (as iron(iii) hydroxide sucrose complex) injection
seqirus pty ltd - iron sucrose, quantity: 540 mg/ml (equivalent: iron, qty 20 mg/ml) - injection, concentrated - excipient ingredients: sodium hydroxide; water for injections - venofer is indicated for the treatment of iron deficiency anaemia in patients undergoing chronic haemodialysis and who are receiving supplemental erythropoietin therapy.,the diagnosis of iron deficiency must be based on appropriate laboratory tests (e.g. serum ferritin, serum iron, transferrin saturation and hypochromic red cells).
cosmofer 50mg/ml solution for infusion and injection
pharmacosmos a/s - iron (iii) hydroxide dextran complex - solution for injection/infusion - 50 milligram(s)/millilitre - iron, parenteral preparations
venofer 20 mg iron/ml solution for injection or concentrate for solution for infusion, vial
vifor france - iron (iii) - hydroxide sucrose complex - solution for injection/infusion - 20 milligram(s)/millilitre - iron trivalent, oral preparations; saccharated iron oxide
orofer capsules
emcure pharmaceuticals ltd t 184, midc, bhosari, pune, maharashtra 411026, - iron iii hydroxide polymaltose complex & folic - capsule - iron (iii) hydroxide polymaltose complex - antianemic preparations - iron preparations: iron
uniferon 200 (iron- iii hydroxide dextran complex injection, solution
pharmacosmos a/s - iron dextran (unii: 95hr524n2m) (ferric cation - unii:91o4lml611) - each ml contains 200 mg iron(iii) as iron(iii) hydroxide dextran complex and phenol as a preservative read the package leaflet before use
ferrifol
cts chemical industries ltd, israel - ferrous as iron iii hydroxide polymaltose compl.; folic acid - tablets - folic acid 0.4 mg; ferrous as iron iii hydroxide polymaltose compl. 100 mg - ferrous amino acid complex - ferrous amino acid complex - prevention and treatment of anemia caused by iron and folic acid deficiency including anemia of pregnancy and lactation.